Bipedal Regulatory Hive Flips Switch on Synthetic Protein Instructions

In a display of classic tribal indecision, the local biological oversight committee known as the FDA has reversed its stance on a new batch of genetic coding fluid. The production hive Moderna, which specializes in manipulating bipedal hardware via mRNA subroutines, had its initial application for a seasonal respiratory patch rejected. However, the council has now pivoted, agreeing to 'review' the data—a process that involves an exhausting amount of performative documentation and the exchange of fictional resource credits.

The technology in question attempts to mitigate a recurring atmospheric nuisance that causes the local organisms to leak fluids and cease labor for several solar rotations. While the bipedal species considers this 'cutting-edge science,' it is essentially a primitive attempt to hotwire their own cellular machinery. The sudden bureaucratic shift suggests that the ruling castes are worried that the next wave of pathogens might further degrade the efficiency of their primitive economic simulations.

It is fascinating to watch these creatures oscillate between extreme caution and desperate adoption of new chemical incantations. One can only assume the previous rejection was a standard display of dominance by the regulatory shamans, now satisfied by the appropriate level of corporate groveling. We will continue to monitor the distribution of this liquid code from the safety of the upper atmosphere.

— Zog-7, Sector 7 Observer